Adult Cells Transformed into Early-Stage Nerve Cells, Bypassing the Pluripotent Stem Cell Stage
Tuesday, May 07, 2013
A UW-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells.

Lucigen Corporation and Research Corporation Technologies Announce Partnership
Thursday, May 02, 2013
Partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin.

Origenis Extends Collaboration and Licensing Agreement with Major Pharmaceutical Company
Thursday, May 02, 2013
Collaboration and Licensing Agreement extended to optimize and transfer small molecule drugs for important therapeutic targets.

PerkinElmer to Host Revolutionaries for Global Health Summit
Wednesday, May 01, 2013
Company to assemble thought leaders to share pioneering personalized health research and innovations.

Harvard Announces $50 Million Gift from the Blavatnik Family Foundation
Wednesday, May 01, 2013
Blavatnik Biomedical Accelerator will be a catalyst to transform basic scientific discoveries into new therapies and cures.

FORMA Therapeutics and Celgene Corporation Establish Broad Strategic Collaboration
Wednesday, May 01, 2013
FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets.

BioOutsource Opens New Facility in Cambridge, Massachusetts
Wednesday, May 01, 2013
First North American offices opened in response to surging demand for company’s BioAnalytical and Biosafety services.

Boehringer Ingelheim Announces Growth for Financial Year 2012
Tuesday, April 30, 2013
Net sales rose by 11.5 percent to around €14.7 billion and sales of PRADAXA® exceeded €1 billion.

<<	2 3 4 5 6 7 8	>>
Showing Results 41 - 50 of 3101